Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Introduction: Interpretation of results from mutation screening of tumour suppressor genes known to harbour high risk susceptibility mutations, such as APC, BRCA1, BRCA2, MLH1, MSH2, TP53, and PTEN, is becoming an increasingly important part of clinical practice. Interpretation of truncating mutations, gene rearrangements, and obvious splice junction mutations, is generally straightforward. However, classification of missense variants often presents a difficult problem. From a series of 20 000 full sequence tests of BRCA1 carried out at Myriad Genetic Laboratories, a total of 314 different missense changes and eight in-frame deletions were observed. Before this study, only 21 of these missense changes were classified as deleterious or suspected deleterious and 14 as neutral or of little clinical significance. Methods: We have used a combination of a multiple sequence alignment of orthologous BRCA1 sequences and a measure of the chemical difference between the amino acids present at individual residues in the sequence alignment to classify missense variants and in-frame deletions detected during mutation screening of BRCA1. Results: In the present analysis we were able to classify an additional 50 missense variants and two in-frame deletions as probably deleterious and 92 missense variants as probably neutral. Thus we have tentatively classified about 50% of the unclassified missense variants observed during clinical testing of BRCA1. Discussion: An internal test of the analysis is consistent with our classification of the variants designated probably deleterious; however, we must stress that this classification is tentative and does not have sufficient independent confirmation to serve as a clinically applicable stand alone method.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whole-Genome Shotgun Assembly and Analysis of the Genome of Fugu rubripes
Aparicio, S., Chapman, J., Stupka, E., Putnam, N., Chia, J.-M., Dehal, P., Christoffels, A., Rash, S., Hoon, S., Smit, A., et al. (2002) · Science · doi:10.1126/science.1072104 · Cited by 1,591
Self-citationGoodman, M., Porter, C. A., Czelusniak, J., Page, S. L., Schneider, H., Shoshani, J., Gunnell, G., & Groves, C. P. (1998) · Molecular Phylogenetics and Evolution · doi:10.1006/mpev.1998.0495 · Cited by 743
Cited by
Tavtigian, S. V., Deffenbaugh, A. M., Yin, L., Judkins, T., Scholl, T., Samollow, P. B., de Silva, D., Zharkikh, A., & Thomas, A. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.033878 · Cited by 669
Self-citationModeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework
Tavtigian, S. V., Greenblatt, M. S., Harrison, S. M., Nussbaum, R. L., Prabhu, S. A., Boucher, K. M., & Biesecker, L. G. (2018) · Genetics in Medicine · doi:10.1038/gim.2017.210 · Cited by 590
“Post P 1⁄4 OddsPath Prior P ð OddsPath 1 ð Þ Prior P þ 1Þ (4)”
BackgroundSelf-citationEaston, D. F., Deffenbaugh, A. M., Pruss, D., Frye, C., Wenstrup, R. J., Allen-Brady, K., Tavtigian, S. V., Monteiro, A. N. A., Iversen, E. S., Couch, F. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/521032 · Cited by 455
“Although the focus of this article is on BRCA1 and BRCA2, similar concerns and issues are found in virtually all complex, genetically heterogeneous diseases for which genetic testing is performed—for example, colon cancer associated with mutations in mismatch repair genes.2 To address the problem of defining which VUS…”
MethodInfluentialSelf-citationComprehensive Molecular Diagnostics in Autosomal Dominant Polycystic Kidney Disease
Rossetti, S., Consugar, M. B., Chapman, A. B., Torres, V. E., Guay-Woodford, L. M., Grantham, J. J., Bennett, W. M., Meyers, C. M., Walker, D. L., Bae, K., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121387 · Cited by 439
Goldgar, D. E., Easton, D. F., Deffenbaugh, A. M., Monteiro, A. N. A., Tavtigian, S. V., & Couch, F. J. (2004) · The American Journal of Human Genetics · doi:10.1086/424388 · Cited by 391
Self-citationFitting a naturally scaled point system to the ACMG/AMP variant classification guidelines
Tavtigian, S. V., Harrison, S. M., Boucher, K. M., & Biesecker, L. G. (2020) · Human Mutation · doi:10.1002/humu.24088 · Cited by 358
Self-citationAdeva, M., El-Youssef, M., Rossetti, S., Kamath, P. S., Kubly, V., Consugar, M. B., Milliner, D. M., King, B. F., Torres, V. E., & Harris, P. C. (2006) · Medicine · doi:10.1097/01.md.0000200165.90373.9a · Cited by 273
Hicks, S., Wheeler, D. A., Plon, S. E., & Kimmel, M. (2011) · Human Mutation · doi:10.1002/humu.21490 · Cited by 223
“…argues the alignment should not only be restricted to true orthologs due to the biological phenomenon of functional diversification among paralogs [Abkevich et al., 2004], but also should sample enough sequences at sufficient evolutionary distance from each other (alignment depth) for the best…”
BackgroundIn silico analysis of missense substitutions using sequence-alignment based methods
Tavtigian, S. V., Greenblatt, M. S., Lesueur, F., Byrnes, G. B., & for the IARC Unclassified Genetic Variants Working Group (2008) · Human Mutation · doi:10.1002/humu.20892 · Cited by 199
Self-citationCollin, R. W. J., van den Born, L. I., Klevering, B. J., de Castro-Miró, M., Littink, K. W., Arimadyo, K., Azam, M., Yazar, V., Zonneveld, M. N., Paun, C. C., et al. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6185 · Cited by 79
Lolas Hamameh, S., Renbaum, P., Kamal, L., Dweik, D., Salahat, M., Jaraysa, T., Abu Rayyan, A., Casadei, S., Mandell, J. B., Gulsuner, S., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30771 · Cited by 42
Metadata
- Authors
- Abkevich, V, Zharkikh, A., Deffenbaugh, A. M., Frank, D., Chen, Y., Shattuck, D., Skolnick, M. H., Gutin, A., & Tavtigian, S. V.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 2004-07
- Volume
- 41
- Issue
- 7
- Pages
- 492-507
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W2141069009
- Cited by
- 157
- References
- 2
- FWCI
- 8.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.